<DOC>
	<DOCNO>NCT00382759</DOCNO>
	<brief_summary>The study aim evaluate efficacy nonmyeloablative conditioning consist fludarabine total body irradiation patient older 60 year age</brief_summary>
	<brief_title>Nonmyeloablative Stem Cell Transplant Elderly</brief_title>
	<detailed_description>A total 35 patient hematological malignancy treat fludarabine ( 30 mg/m2 x 3-5 day ) 200 cCy TBI follow allogeneic hematopoietic stem cell transplantation ( HSCT ) matched-sibling donor . Neutrophil recovery occur 89 % patient median time 15 day . On day +30 , 10 patient &gt; 95 % donor chimerism , 21 patient mixed chimerism . The cumulative probability grade II-IV acute GVHD chronic GVHD 51 % 84 % respectively . Transplant-related mortality 100 day 1 year 5 % 9 % respectively . The probability 1-year overall ( OS ) progression-free survival ( PFS ) 55 % 47 % respectively . The estimated 1-year probability OS PFS patient early disease stag 87 % 74 % respectively , significantly high survival PFS estimate 12 % obtain patient advanced disease stage time transplant</detailed_description>
	<mesh_term>Neoplasms</mesh_term>
	<criteria>patient myeloid lymphoid malignancy &gt; 60 year old potentially treatable stem cell transplant lack HLAidentical sibling donor</criteria>
	<gender>All</gender>
	<minimum_age>60 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2009</verification_date>
</DOC>